Merck Opens Largest M Lab™ Collaboration Center in Shanghai, Focused on Drug Discovery and Biopharmaceutical Innovation

— Dedicated to improving and optimizing drug discovery, development, and manufacturing

——ShanghaiM Lab™ Collaboration Center features a comprehensive laboratory offering customized solutions, validation services, training, and hands-on applications.

—The Shanghai Hub is Merck’s newest and largestM Lab™ Collaboration Centers. Merck has established nine M Lab™ Collaboration Centers worldwide.

Darmstadt, Germany, July 10, 2020 /PRNewswire/ -- Leading science and technology company Merck has opened its M Lab™ Collaboration Hub in Shanghai. The Shanghai hub is the largest among the company’s nine global centers.

Wu Boda, Member of the Executive Board of Merck KGaA and CEO of the Life Science Business SectorUdit Batra) stated: “With the booming development of the Asian pharmaceutical industry and the increasing emphasis on novel drug therapies, China is continuously intensifying its R&D efforts in advanced therapies such as cell and gene therapies. Our M Lab™ Collaboration Center provides customized solutions and services to help biopharmaceutical and biological product companies improve processes from drug discovery and development to manufacturing, thereby reducing costs and accelerating time-to-market.”

Merck’s newly established M Lab™ Collaboration Center is located in Pudong, the hub of biomedical science and research in Shanghai, with a total laboratory area of approximately 10,000 square meters.

The newly established M Lab™ Collaboration Center in Shanghai offers customized solutions tailored for China’s life sciences sector to help advance drug development. The new center features lab-scale and process development support laboratories, providing non-GMP (Good Manufacturing Practice) laboratory space where pharmaceutical and biopharmaceutical manufacturers can explore ideas, learn innovative technologies, and work side-by-side with Merck scientists and engineers to address critical process development and manufacturing challenges. Customers can participate in product demonstrations, hands-on training, formal bioprocessing educational courses and experiments, and apply best practices and novel approaches to develop, optimize, and scale up processes, as well as streamline global technology transfer.

Customers can also utilize the following Merck products:

In addition, the center also features newBioReliance^®End-to-End SolutionsGMP Manufacturing Center, providing contract development and manufacturing organization (CDMO) services to customers in China and the Asia-Pacific region.

As a leading innovator in the pharmaceutical and biopharmaceutical industries, Merck KGaA is committed to playing an active role in China’s transition toward an innovation-driven economy. Through this new center, Merck KGaA will collaborate with local and regional customers to enhance drug quality and safety, while providing training and knowledge transfer.

All Merck press releases are distributed via email simultaneously with their publication on the Merck website. Please visitwww.merckgroup.com/subscribe, register online, change options, or discontinue this service.

Merck Overview

Merck is a leading science and technology company focused on three key areas: healthcare, life science, and performance materials. Approximately 56,000 employees worldwide work at Merck to create sustainable and enjoyable ways of living, improving the daily lives of millions of people. From advancing gene-editing technologies and discovering unique approaches to treating the most challenging diseases, to supporting smart devices, Merck is present everywhere. In 2019, Merck generated sales of €16.2 billion across 66 countries.

Scientific exploration and responsible business practices are key to Merck’s scientific and technological progress. This has also been the driving force behind Merck’s continuous development since its founding in 1668. The founding family still holds the majority of shares in the publicly listed company. Merck owns the “Merck” name and brand globally, with the only exceptions being the United States and Canada. In these two countries, Merck operates its healthcare business under EMD Serono, its life science business under MilliporeSigma, and its performance materials business under EMD Performance Materials.

Image:https://mma.prnasia.com/media2/1200596/milliporesigma_m_lab_shanghai.jpg?p=medium600